Medicine’s Financial Contamination

Sep 18, 2018 | Conflict of Interest, Disclosure, Patient Safety

Catch the New York Times editorial on the fall of Dr. José Baselga, the former chief scientific officer of Memorial Sloan Kettering Cancer Center, resulting from failure to disclose payments from drug companies.

0 Comments

Pin It on Pinterest